BMRABiomerica, Inc.
1.610USD+5.92%Mkt Cap: 4.98M $P/E:

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worl…

Key Statistics

Company
Market Cap4.98M $
Enterprise Value3.76M $
Revenue (TTM)4.33M $
Gross Profit498.00K $
Net Income (TTM)-4.97M $
Revenue/Share1.608 USD
Last Price1.610 USD
Fiscal Year EndMay 2025
MR QuarterFeb 2026
Employees53
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)4.06
PEG
EV/EBITDA-0.71
EV/Revenue0.87
P/S1.13
P/B1.45
EPS (TTM)-1.65
EPS (Forward)0.39
52W Range
1.4507% of range3.600
52W High3.600 USD
52W Low1.450 USD
Profitability
Gross Margin9.38%
Oper. Margin-131.51%
EBITDA Margin-121.75%
Profit Margin-93.64%
ROE-121.14%
ROA-83.65%
Growth
Revenue Growth-11.80%
Earnings Growth
Cash Flow & Leverage
Operating CF-3.84M $
CapEx (TTM)37.00K $
FCF Margin-46.88%
FCF Yield-40.77%
Net Debt-1.14M $
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.11
Current Ratio2.64
Quick Ratio1.46
Book Value/Sh1.095 USD
Cash/Share0.4320 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:8
Split DateApr 21, 2025
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.3.09M
Float2.77M
Insiders15.24%
Institutions4.05%
Short Interest
Short Ratio3.4d
Short % Float0.84%
Short % Out.0.75%
Shares Short23.05K
Short (prev mo.)32.61K
Technical
SMA 501.690 (-4.7%)
SMA 2002.153 (-25.2%)
Beta0.31
S&P 52W Chg18.16%
Avg Vol (30d)6.24K
Avg Vol (10d)5.08K
Technical Indicators
RSI (14)38.2
MACD-0.0435
MACD Signal-0.0521
MACD Hist.+0.0086
BB Upper1.655 USD
BB Middle1.579 USD
BB Lower1.504 USD
BB Width9.55%
ATR (14)0.0732 USD
Vol Ratio (20d)1.22x